Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Biofrontera
Biofrontera
(BFRI)
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Company Revenue
Quarterly
Quarterly
Annual
Annual
Projections
*Quarterly sales USD (in millions)
Mock data
Subscribe for the real data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Aktipak
Erythromycin
,
Benzoyl peroxide
2000-11-27
Acne vulgaris
,
Bacterial infections
,
Gonorrhea
,
Campylobacter infections
,
Whooping cough
,
Chlamydia infections
,
Streptococcal infections
,
Legionnaires' disease
,
Urethritis
,
Bacterial eye infections
,
Syphilis
,
Staphylococcal infections
,
Mycoplasma infections
,
Protozoan infections
,
Gastroenteritis
,
Chancroid
,
Erythrasma
,
Rosacea
Ameluz
Aminolevulinic acid
2016-05-10
2028-2040
Actinic keratosis
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Aminolevulinic acid
neoplasms
,
head and neck neoplasms
,
skull base neoplasms
,
brain neoplasms
,
meningioma
,
ovarian neoplasms
,
pituitary neoplasms
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use